SIONSionna Therapeutics, Inc.

HealthcareUSD
$51.04

The financials

Sionna Therapeutics, Inc. by the numbers

Sionna Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$32M−$22Mn/a
Net income−$30M−$18Mn/a
Diluted EPS−$0.66−$410.00n/a

Biotechnology

Ranks #88 of 145 by Smart Score

Compare peers
VRDN+0.40%
Viridian Therapeutics, Inc.
PVLA+4.9%
Palvella Therapeutics, Inc.
LKFT-0.59%
Lakefront Biotherapeutics NV
PGEN+2.2%
Precigen, Inc.
STOK+0.03%
Stoke Therapeutics, Inc.
HRMY-0.93%
Harmony Biosciences Holdings, Inc.